Global Prefilled Syringes Market Insights Forecasts to 2033.

• The Global Prefilled Syringes Market Size was Valued at USD 6.71 Billion in 2023
• The Market Size is Growing at a CAGR of 9.02% from 2023 to 2033
• The Worldwide Global Prefilled Syringes Market Size is Expected to Reach USD 15.91 Billion by 2033
• Asia Pacific Market is expected to grow the fastest during the forecast period

Get more details on this report -

Request Free Sample PDF

The Global Prefilled Syringes Market Size is anticipated to exceed USD 15.91 Billion by 2033, Growing at a CAGR of 9.02% from 2023 to 2033.

 

Market Overview

Prefilled syringes are one of the main packaging systems that do not require manual filling because they are pre-loaded with an exact dose of parenteral medication in an injectable format. They provide a number of benefits, such as easy usage, accurate dosage, a lower chance of contamination, and less medication waste. By lowering the number of patient visits to the healthcare practitioner, these drug delivery systems contribute to the decrease in global healthcare expenses. Currently, a variety of prefilled syringes are available on the market. These include flush syringes, which contain sterile solution and are used to clear intravenous catheters, cannulas, or other vascular access devices; dual chamber prefilled syringes, which store liquid and lyophilized components in separate chambers; and safety syringes, which are fitted with mechanisms to prevent needle stick injuries and guarantee healthcare worker safety. Prefilled syringes are expected to become more widely available in the near future due to factors like the growing popularity of self-injecting parenteral devices, continuous technological improvements, and consumers' preference for at-home healthcare services. The prefilled syringe market is driven by the increased approval of prefilled syringes by the FDA and TGA. For instance, in March 2023, Emerphed (ephedrine sulfate injection) in 25 mg/5 mL and 50 mg/10 mL single-dose pre-filled syringes from Nexus Pharmaceuticals was approved by the FDA to treat hypotension during anesthesia.

 

Report Coverage

This research report categorizes the market for the global prefilled syringes market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global prefilled syringes market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global prefilled syringes market.

 

Driving Factors

The prefilled syringe market is driven by various factors, such as the development of biological therapies. Traditional therapeutic choices are being progressively replaced by biologic pharmaceuticals and therapeutic vaccines because of their greater efficacy, safety, and reduced adverse effects. Due to their inherent instability, the continuous introduction of biologic medications has created a need for creative packaging solutions to preserve their potency. Since any interaction with food or digestive enzymes causes them to deteriorate, parenteral delivery is preferable for the biologic medications currently under development. Prefilled syringes are therefore seen as the best container for storing these medications. In addition, prefilled syringe adoption is on the rise due to a number of chronic conditions, including diabetes, autoimmune diseases, heart disease, and others, which compel patients to self-administer medication. This is regarded as one of the key factors propelling the market's growth. Furthermore, it is anticipated that the prevalence of numerous chronic and lifestyle disorders will quicken the market's overall expansion. According to the World Health Organization (WHO), chronic diseases (NCDs) account for 41 million annual deaths worldwide, or 74% of all fatalities.

 

Restraining Factors

The availability of cheaper medications is hampering the global prefilled syringe market. Because the process of manufacturing them entails considerable expenditures, prefilled syringes are much more expensive than disposable syringes. Over the forecast period, one of the biggest challenges facing the prefilled syringe market is expected to be the cheaper, readily available disposable syringe alternative.

 

Market Segmentation

The Global Prefilled Syringe Market share is classified into type, material, application and end users

• The disposable segment is expected to hold the largest share of the global prefilled syringe market during the forecast period.

Based on the type, the global prefilled syringes market is divided into disposable, reusable. Among these, the disposable segment is expected to hold the largest share of the global prefilled syringe market during the forecast period. The decreased risk of contamination by these syringes is expected to increase demand for them. Needle stick injuries are brought on by risky behaviors, including using a prefilled syringe and needle repeatedly without following medical professionals' advice on precautionary measures. Moreover, patients' safety is not guaranteed by conventional disposable prefilled syringes, even if they protect the receiver. As a result, hospitals and home care settings are using more disposable equipment due to a strong desire for patient safety.

 

• The glass syringes segment is expected to grow at the fastest pace in the global prefilled syringes market during the forecast period.

Based on the material, the global prefilled syringes market is divided into glass syringes and plastic syringes. Among these, the glass syringes segment is expected to grow at the fastest pace in the global prefilled syringes market during the forecast period. The industry standard for prefilled syringes at the moment is glass syringes. Glass syringes are simple to use and are used by healthcare practitioners to check for any particle contaminants. For healthcare experts, glass is a dependable substitute because of its inertness and transparency, which guarantee the purity of the dosage.

 

• The diabetes segment is expected to hold the greatest share of the global prefilled syringes market during the forecast period.

Based on the application, the global prefilled syringes market is divided into anaphylaxis, diabetes & others. Among these, the diabetes segment is expected to hold the greatest share of the global prefilled syringes market during the forecast period. The increased prevalence of diabetes and large patient base are propelling the global prefilled syringe market. According to the International Diabetes Federation (IDF), there are about 540 million people with diabetes worldwide, and this number will reach 783 million by the end of 2045. 

 

• The hospital segment is expected to grow at the fastest pace in the global prefilled syringes market during the forecast period.    

Based on the end users, the global prefilled syringes market is divided into hospitals, mail order pharmacies, ambulatory surgery centers and others. Among these, the hospital segment is expected to grow at the fastest pace in the global prefilled syringes market during the forecast period. Prefilled syringes are primarily used by hospitals for their wide range of applications. In addition, increased focus on the development of healthcare infrastructure in developing regions such as Asia, the Pacific, and Africa is fueling the growth of the global prefilled syringe market.

 

Regional Segment Analysis of the Global Prefilled Syringes Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

Europe is anticipated to hold the largest share of the global prefilled syringes market over the predicted timeframe.

Get more details on this report -

Request Free Sample PDF

Europe is anticipated to hold the largest share of the global prefilled syringe market over the predicted timeframe. The growth of global prefilled syringe market is driven by the European region. Due the preference of the healthcare physicians to the injectable products are to decrease the needle related injuries. In addition, the presence of various key players such as Owen Mumford Ltd., Gerresheimer AG, SCHOTT Group, and others in the

 

Europe region is accelerating the growth of the region. These companies have reinforced their presence in the European region. Therefore, the entry of the new player in these regions is quite difficult. Also, they have expanded their business worldwide and are dominating the global market, which adds to their revenue in the European region.

 

Asia-Pacific is expected to grow the fastest during the forecast period. Some demographic factors, such as growing chronic disease prevalence and increased population, are fueling the global prefilled syringe market. Also, growing demand for injectable drugs for the treatment of chronic diseases in India and China is expected to accelerate the growth of the global prefilled syringe market in the region. 

 

Competitive Analysis:

The report offers an appropriate analysis of the key organizations/companies involved within the global prefilled syringes market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Owen Mumford Ltd.
• Gerresheimer AG
• SCHOTT group
• Becton
• Dickinson and Company
• West Pharmaceutical Services, Inc.
• Baxter International, Inc.
• Takeda Pharmaceutical Company Limited.
• Ompi
• Catalent, Inc.
• Genentech
• Weigao Group
• Vetter Pharma International GmbH
• Nipro Corporation
• Teruma
• SHL Medical AG
• Oval Medical Technologies
•  YPSOMED
• Others.

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

• In February 2022, FDA has approved TAKHZYRO® a prefilled syringe of Takeda company for the prevention of heredity attacks in adults and pediatric patients.

 

• In April 2021, Genentech has announced that the FDA has approved the Xolair prefilled syringe for the supplemental biologic’s licenses application.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Prefilled Syringes Market based on the below-mentioned segments: 

 

Global Prefilled Syringes Market, By Type

• Disposable
• Reusable

 

Global Prefilled Syringes Market, By Material

• Glass Syringes
• Plastic Syringes

 

Global Prefilled Syringes Market, By Application

• Anaphylaxis
• Diabetes
• Cancer
• Others

 

Global Prefilled Syringes Market, By End Users

• Hospitals
• Mail-Order Pharmacies
• Ambulatory Surgery Centers
• Others

 

Global Prefilled Syringes Market, By Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa